Finland· FI-REL-REL35729
Eurartesim
A artenimol und piperaquin product containing piperaquine tetraphosphate + artenimol, registered in Finland by ALFASIGMA S.p.A.. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Artenimol und piperaquin is registered in 9 of 19 countries.
Countries holding a registration under ATC P01BF05 (artenimol und piperaquin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Artenimol und piperaquin · ATC P01BF05
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Fimea (Finland)- Active substance
- Piperaquine tetraphosphate + Artenimol
- Manufacturer
- ALFASIGMA S.p.A.
- Country
- Finland (FI)
- ATC code
- P01BF05
- ATC class
- Artenimol und Piperaquin
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Artenimol und piperaquin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandEurartesimAlfasigma S.p.A.
- IrelandEurartesim 160 mg/20 mg film-coated tabletsSigma-Tau Industrie Farmaceutiche Riunite SpA
- IcelandEurartesimAlfasigma S.p.A.
- NetherlandsEurartesim 160 mg/20 mg filmomhulde tablettenAlfasigma S.p.A
- SpainEURARTESIM 320 mg/ 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAlfasigma S.P.A.
- FranceEURARTESIM 320 mg/40 mg, comprimé pelliculéALFASIGMA (ITALIE)
- United KingdomEurartesim 320mg/40mg tabletsLogixx Pharma Solutions Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d5c3a3e5-604f-4bf1-a3f3-a2a84fd45c2a GET /v1/drugs/d5c3a3e5-604f-4bf1-a3f3-a2a84fd45c2a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "3",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "320 mg / 40 mg",
"atc_label": "artenimoli ja piperakiini",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/11/716/001-004,006-007",
"fimea_rel_id": "REL35729",
"authorised_at": "2011-10-27"
}See everything about artenimol und piperaquin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.